Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants
- PMID: 10027650
- DOI: 10.1016/s0166-3542(98)00057-6
Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants
Abstract
We have characterized the differential actions of acyclovir and penciclovir against varicella-zoster virus (VZV) in cell culture by comparing the frequency of appearance of resistant viruses followed by their characterization. Cells were infected with cell-free virus and the cultures were successively treated with increasing concentrations of acyclovir or penciclovir. Drug-resistant viruses were selected in the presence of 6 microg/ml of acyclovir or penciclovir. The emergence frequency of resistant viruses was significantly higher following acyclovir exposure than following penciclovir exposure (Fisher's exact test, P<0.0001), possibly reflecting virus growth differences under these experimental conditions. Based on antiviral drug susceptibility and thymidine kinase (TK) activity assays, 11 acyclovir-resistant variants from seven experiments using three virus strains (Kawaguchi strain, Oka varicella vaccine strain and a clinical isolate from a zoster patient) were found to be TK-deficient. Sequence analysis of TK-deficient variants of the Kawaguchi strain revealed deletions that caused frameshifts, resulting in premature termination in the TK gene.
Similar articles
-
Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS.J Virol. 1993 Feb;67(2):1024-33. doi: 10.1128/JVI.67.2.1024-1033.1993. J Virol. 1993. PMID: 8380452 Free PMC article.
-
Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.Antimicrob Agents Chemother. 1999 Oct;43(10):2412-6. doi: 10.1128/AAC.43.10.2412. Antimicrob Agents Chemother. 1999. PMID: 10508017 Free PMC article.
-
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?Antiviral Res. 2004 Mar;61(3):181-7. doi: 10.1016/j.antiviral.2003.10.003. Antiviral Res. 2004. PMID: 15168799
-
[Antiviral resistance of herpes simplex virus and varicella-zoster virus].Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:480-6. Nihon Rinsho. 2007. PMID: 17455667 Review. Japanese. No abstract available.
-
[Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].Ann Biol Clin (Paris). 2003 Jan-Feb;61(1):33-40. Ann Biol Clin (Paris). 2003. PMID: 12604384 Review. French.
Cited by
-
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections.Pharmacol Ther. 2020 May;209:107512. doi: 10.1016/j.pharmthera.2020.107512. Epub 2020 Feb 22. Pharmacol Ther. 2020. PMID: 32097670 Free PMC article. Review.
-
Safety, tolerability of ES16001, a novel varicella zoster virus reactivation inhibitor, in healthy adults.Eur J Med Res. 2021 Aug 12;26(1):92. doi: 10.1186/s40001-021-00565-z. Eur J Med Res. 2021. PMID: 34384499 Free PMC article. Clinical Trial.
-
Identification of ribonucleotide reductase mutation causing temperature-sensitivity of herpes simplex virus isolates from whitlow by deep sequencing.Clin Case Rep. 2015 Jun;3(6):461-7. doi: 10.1002/ccr3.270. Epub 2015 Apr 22. Clin Case Rep. 2015. PMID: 26185649 Free PMC article.
-
Anti-varicella-zoster virus activity of cephalotaxine esters in vitro.J Microbiol. 2019 Jan;57(1):74-79. doi: 10.1007/s12275-019-8514-z. Epub 2018 Nov 19. J Microbiol. 2019. PMID: 30456755 Free PMC article.
-
Inhibitory effect of Alantolactone against varicella-zoster virus in vitro.Virol J. 2025 May 9;22(1):138. doi: 10.1186/s12985-025-02759-x. Virol J. 2025. PMID: 40346667 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical